ABIVAX Société Anonyme logo

ABIVAX Société Anonyme

EPA:ABVX.PA

Overview | Financials
Company Name ABIVAX Société Anonyme
Symbol ABVX.PA
Currency EUR
Price 10.14
Market Cap 641,692,348
Dividend Yield 0%
52-week-range 7.89 - 17.04
Industry Biotechnology
Sector Healthcare
CEO Mr. Marc M. P. de Garidel M.B.A.
Website https://www.abivax.com

An error occurred while fetching data.

About ABIVAX Société Anonyme

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for

Related Stocks

Guerbet SA logo

Guerbet SA

GBT.PA

36 EUR

Bastide Le Confort Médical SA logo

Bastide Le Confort Médical SA

BLC.PA

20.15 EUR

Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

MITRA.BR

0.216 EUR

Prim, S.A. logo

Prim, S.A.

PRM.MC

10.65 EUR

Cegedim SA logo

Cegedim SA

CGM.PA

12.55 EUR

Laboratorio Reig Jofre, S.A. logo

Laboratorio Reig Jofre, S.A.

RJF.MC

2.7 EUR

Eurobio Scientific Société anonyme logo

Eurobio Scientific Société anonyme

ALERS.PA

24.9 EUR

Transgene SA logo

Transgene SA

TNG.PA

1.038 EUR

Carmat SA logo

Carmat SA

ALCAR.PA

1.75 EUR

Innate Pharma S.A. logo

Innate Pharma S.A.

IPH.PA

2.05 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD